Page 7 of 10
New Journal of Chemistry
Please do not adjust margins
Journal Name
ARTICLE
HRMS (ESI) calcd for C27H36NO2 [M + H]+ m/z 406.2741, found 7.36-7.22 (m, 5H), 7.05 (dd, J = 4.9, 3.8 Hz, 2H), 3.84 (s, 2H), 3.38
DOI: 10.1039/C8NJ01975D
406.2752.
(s, 2H), 3.05 (m, 2H), 2.85-2.77 (m, 2H), 2.03 (m, 2H), 1.62 (m,
1,1'-(1-Methylpyrrolidine-2,5-cis-diyl)bis(oct-7-yn-2-one)
2H); 13C NMR (CDCl3, 75 MHz)
192.2, 144.8, 133.8, 132.3,
(3bc): Prepared following the general procedure using a 129.3, 128.6, 128.5, 128.2, 127.4, 62.3, 58.6, 46.4, 30.1; HRMS
solution of 2b (100 mg, 0.35 mmol) in THF (1.4 mL) and a (ESI) calcd for C23H24NO2S2 [M + H]+ m/z 410.1243, found
solution of hexyn-1-yllithium resulting from the addition of n- 410.1248.
BuLi 1.6 M in hexane (1.09 mL, 1.75 mmol, 5 equiv) to 1-hexyne 2-{(2S*,5R*)-1-Benzyl-5-[2-oxo-2-(thien-2-yl)ethyl] pyrrolidin-
(199 µL, 1.75 mmol, 5 equiv) in THF (2mL). 3bc is isolated as 2-yl}-N-methylacetamide (4af): Prepared following the general
yellow oil (62 mg, 54%, Method A).
max/cm-1 (neat) 2959, 2933, procedure using a solution of 2a (127 mg, 0.35 mmol) in THF
2.89-2.79 (m, 4H), (1.4 mL) and 2-thienyllithium solution 1 M in THF (1.75 mL, 1.75
2209, 1667, 1158; 1H NMR (CDCl3, 300 MHz)
2.56-2.48 (m, 2H), 2.35 (t, J = 6.9 Hz, 4H), 2.26 (s, 3H), 2.00 (m, mmol, 5 equiv, Method A) or 2-thienylmagnesium bromide
2H), 1.57-1.49 (m, 5H), 1.47-1.37 (m, 5H), 0.91 (t, J = 7.3 Hz, 6H); solution 1 M in THF (1.75 mL, 1.75 mmol, 5 equiv, Method B),
13C NMR (CDCl3, 75 MHz)
186.8, 95.1, 81.4, 62.7, 51.0, 39.0, or a solution of TMEDA (210 µL, 1.4 mmol, 4 equiv) and 2-
29.8, 29.5, 22.1, 18.8, 13.6; HRMS (ESI) calcd for C21H32NO2 [M thienyllithium solution 1 M in THF (1.4 mL, 1.4 mmol, 4 equiv,
+ H]+ m/z 330.2428, found 330.2434.
1,1'-(1-Methylpyrrolidine-cis-2,5-diyl)bis{7-[(tetrahydro-2H-
pyran-2-yl)oxy]hept-3-yn-2-one} (3bd): Prepared following the 1648, 1555, 1413, 723, 698; 1H NMR (CDCl3, 300 MHz)
Method C), affording 4af (31 mg, 23%, Method A; 46 mg, 34%,
Methods B and C) as brown oil.
max/cm-1 (neat) 3296, 2874,
7.58 (d,
general procedure using a solution of 2b (46 mg, 0.16 mmol) in J = 3.5 Hz, 1H), 7.54 (m, 1H), 7.39 (d, J = 3.5 Hz, 1H), 7.34-7.21
THF (0.65 mL) and a solution of 5-[(tetrahydro-2H-pyran-2- (m, 5H), 7.04 (m, 1H), 3.85 (d, J = 13.3 Hz, 1H), 3.68 (d, J = 13.6
yl)oxy]pentyn-1-yllithium resulting from the addition of n-BuLi Hz, 1H), 3.38 (m, 1H), 3.12 (m, 1H), 2.89 (m, 2H), 2.75 (d, J = 4.8
1.6 M in hexane (500 µL, 0.8 mmol, 5 equiv) to 5-[(tetrahydro- Hz, 3H), 2.33 (m, 2H), 1.99-1.87 (m, 2H), 1.69-1.59 (m, 2H); 13C
2H-pyran-2-yl)oxy]pentyne (135 mg, 0.8 mmol, 5 equiv) in THF NMR (CDCl3, 75 MHz) 191.6, 172.0, 144.5, 138.4, 134.1, 132.3,
(2mL)., affording 3bd as yellow oil (45 mg, 56%, Method A). 129.5, 128.7, 128.2, 127.8, 62.4, 62.1, 58.0, 45.3, 39.2, 29.8,
1
max/cm-1 (neat) 2941, 2870, 2211, 1169, 1158, 1136, 1075; H 28.8, 25.8; HRMS (ESI) calcd for C20H25N2O2S [M + H]+ m/z
NMR (CDCl3, 300 MHz)
4.56 (t, J = 2.7 Hz, 2H), 3.84-3.76 (m, 357.1631, found 357.1630.
4H), 3.53-3.41 (m, 4H), 3.02 (s, 3H), 2.49 (t, J = 7.0 Hz, 4H), 2.39 2,2'-(1-Methylpyrrolidine-2,5-cis-diyl)bis[1-(thien-2-
(m, 4H), 2.14 (m, 2H), 1.89-1.80 (m, 6H), 1.78-1.61 (m, 4H), 1.58- yl)ethanone] (3bf): Prepared following the general procedure
1.43 (m, 10H); 13C NMR (CDCl3, 75 MHz)
186.0, 99.0, 95.2, using a solution of 2b (100 mg, 0.35 mmol) in THF (1.4 mL) and
81.2, 65.7, 63.1, 62.4, 50.1, 38.5, 30.7, 29.1, 28.1, 25.5, 19.6, 2-thienyllithium solution 1 M in THF (1.75 mL, 1.75 mmol, 5
16.1; HRMS (ESI) calcd for C29H44NO6 [M + H]+ m/z 502.3163, equiv, Method A) or 2-thienylmagnesium bromide solution 1 M
found 502.3160.
in THF (1.75 mL, 1.75 mmol, 5 equiv, Method B), affording 3bf
2-[(2R*,5S*)-1-methyl-5-(2-oxo-2-phenylethyl) pyrrolidin-2- (48 mg, 41%, Method A; 21 mg, 18%, Method B) as brown oil.
1
yl]-N-methylacetamide (4be): Prepared following the general
procedure using a solution of 2b (100 mg, 0.35 mmol) in THF (CDCl3, 300 MHz)
(1.4 mL) and phenyllithium solution 1.9 M in dibutyl ether (0.9 2H), 7.13 (m, 2H), 3.28-3.22 (m, 2H), 2.98-2.91 (m, 4H), 2.38 (s,
mL, 1.75 mmol, 5 equiv, Method A) or phenylmagnesium 3H), 2.08 (m, 2H), 1.51 (m, 2H); 13C NMR (CDCl3, 75 MHz)
max/cm-1 (neat) 2973, 1650, 1517, 1413, 1234, 720; H NMR
7.71 (d, J = 3.7 Hz, 2H), 7.63 (d, J = 4.9 Hz,
bromide solution 1 M in THF (1.75 mL, 1.75 mmol, 5 equiv, 191.9, 144.8, 134.0, 132.3, 128.3, 63.3, 44.7, 39.3, 29.8; HRMS
Method B), affording 4be as yellow oil (66.5 mg, 42%, Method (ESI) calcd for C17H20NO2S2 [M + H]+ m/z 334.0930, found
A; 47.5 mg, 30%, Method B);
1411; 1H NMR (CDCl3, 300 MHz)
max/cm-1 (neat) 3421, 1737, 1682, 334.0933.
7.95 (d, J = 7.3 Hz, 2H), 7.86 2-{(2S*,5R*)-1-Methyl-5-[2-oxo-2-(thien-2-yl)ethyl]pyrrolidin-
(br., 1H), 7.67 (m, 1H), 7.47 (t, J = 7.5 Hz, 2H), 3.32 (dd, J = 15.3, 2-yl}-N-methylacetamide (4bf): Prepared following the general
3.6 Hz, 1H), 3.06 (dd, J = 15.6, 7.9 Hz, 1H), 2.97 (m, 1H), 2.78 (d, procedure using a solution of 2b (100 mg, 0.35 mmol) in THF
J = 4.8 Hz, 3H), 2.68 (tt, J = 8.1, 4.4 Hz, 1H), 2.52 (dd, J = 16.0, 4.7 (1.4 mL) and 2-thienyllithium solution 1 M in THF (1.75 mL, 1.75
Hz, 1H), 2.38 (dd, J = 11.0, 4.9 Hz, 1H), 2.32 (s, 3H), 2.13-2.03 (m, mmol, 5 equiv, Method A) or 2-thienylmagnesium bromide
1H), 1.98-1.86 (m, 1H), 1.68-1.58 (m, 1H), 1.56-1.43 (m, 1H); 13
NMR (CDCl3, 75MHz) 198,7, 171.9, 137.1, 133.3, 128.7, 128.0, a solution of TMEDA (210 µL, 1.4 mmol, 4 equiv) and 2-
C
solution 1 M in THF (1.75 mL, 1.75 mmol, 5 equiv, Method B) or
63.7, 63.4, 43.3, 38.6, 37.4, 29.5, 27.8, 25.7; HRMS (ESI) calcd thienyllithium solution 1 M in THF (1.4 mL, 1.4 mmol, 4 equiv,
for C16H23N2O2 [M+ H] + m/z 275.1754, found 275.1766.
2,2'-(1-Benzylpyrrolidine-2,5-cis-diyl)bis[1-(thien-2-yl)
ethanone] (3af): Prepared following the general procedure 2357, 1560, 1680, 1412, 859; H NMR (CDCl3, 400 MHz)
Method C), affording 4bf (25 mg, 25%, Method A; 46 mg, 46%,
Method B; 41 mg, 41%, Method C) as brown oil.
max/cm-1 (neat)
7.83
1
using a solution of 2a (127 mg, 0.35 mmol) in THF (1.4 mL) and (s, 1H), 7.72 (dd, J = 3.8, 1.0 Hz, 1H), 7.65 (d, J = 4.9 Hz, 1H), 7.14
2-thienyllithium solution 1 M in THF (1.75 mL, 1.75 mmol, 5 (dd, J = 4.9, 3.8 Hz, 1H), 3.17 (m, 2H), 2.95 (m, 1H), 2.76 (d, J =
equiv, Method A) or 2-thienylmagnesium bromide solution 1 M 4.8 Hz, 3H), 2.67 (m, 1H), 2.50 (dd, J = 16.0, 4.7 Hz, 1H), 2.34 (d,
in THF (1.75 mL, 1.75 mmol, 5 equiv, Method B), affording 3af J = 3.7 Hz, 1H), 2.32 (s, 3H), 2.04 (m, 1H), 1.91 (m, 1H), 1.61 (m,
(65 mg, 45%, Method A; 33 mg, 23%, Method B) as brown oil. 1H), 1.55 (m, 1H); 13C NMR (CDCl3, 100 MHz)
191,4, 171.9,
1
max/cm-1 (neat) 1967, 1663, 1354, 1057, 720; H NMR (CDCl3, 144.6, 134.0, 132.1, 128.2, 63.6, 63.5, 43.8, 38.5, 37.3, 29.3,
300 MHz) 7.58 (dd, J = 4.9, 1.0 Hz, 2H), 7.44 (d, J = 2.9 Hz, 2H),
This journal is © The Royal Society of Chemistry 20xx
J. Name., 2013, 00, 1-3 | 7
Please do not adjust margins